Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AAPG stock hub

Ascentage Pharma Group International has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AAPGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AAPG

In the news

Latest news · AAPG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-154.6

P25 -106.6P50 -46.9P75 -3.1

ROIC-28.8

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AAPG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

CNY

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002023311
Company name	Ascentage Pharma Group International
Country	China
Country code	US
Cusip	04563G101
Employees	767
Employees Change	200%
Employees Change Percent	35.27
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-01-24
Isin	US04390B1052
Last refreshed	2026-05-10
Market cap	$2B
Market cap category	Mid-Cap
Price	$21.5
Price currency	USD
Rev Per Employee	107,018x
Sector	Healthcare
Sic	2834
Symbol	AAPG
Website	https://www.ascentage.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.86%
EV/Sales	23.59x
FCF yield	-8.81%
P/B ratio	10.51x
P/S ratio	24.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-211.14%
EBITDA Margin	-198.15%
Gross margin	91.48%
Gross Profit	$75.1M
Gross Profit Growth	-44.81%
Gross Profit Growth Q	368.1%
Gross Profit Growth3 Y	40.91%
Gross Profit Growth5 Y	118.75%
Net Income	$-177.7M
Net Income Growth Years	0%
Pretax Margin	-215.29%
Profit Margin	-216.47%
Profit Per Employee	$-231,657
ROA	-23.02
Roa5y	-19.46
ROCE	-52.24
ROE	-154.6
Roe5y	-191.8
ROIC	-28.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11.05%
EPS Growth Years	0
Revenue Growth	-41.46x
Revenue Growth Q	116.96x
Revenue Growth Years	0x
Revenue Growth3 Y	39.89x
Revenue Growth5 Y	115.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.17
Assets	$566.7M
Cash	$353.5M
Current Assets	$432.9M
Current Liabilities	$241.6M
Debt	$283M
Debt Equity	$1.48
Equity	$190.8M
Interest Coverage	-22.42
Liabilities	$375.9M
Long Term Assets	$133.8M
Long Term Liabilities	$134.3M
Net Cash	$70.4M
Net Cash By Market Cap	$3.51
Net Debt Equity	$-0.37
Tangible Book Value	$176.4M
Tangible Book Value Per Share	$0.48
WACC	7.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.79
Inventory Turnover	2.78
Net Working Capital	$7.3M
Quick ratio	1.69
Working Capital	$186M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.9%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11.04%
200-day SMA	31.46
50-day SMA	23.99
50-day SMA vs 200-day SMA	50under200
All Time High	48.45
All Time High Change	-55.62%
All Time High Date	2025-08-22
All Time Low	16.5
All Time Low Change	30.3%
All Time Low Date	2025-01-24
ATR	0.87
Beta	0.72
Ch YTD	-18.06
High	21.9
High52	48.45
High52 Date	2025-08-22
High52ch	-55.62%
Low	21.32
Low52	19.11
Low52 Date	2026-03-20
Low52ch	12.51%
Ma50ch	-10.36%
Price vs 200-day SMA	-31.66%
RSI	37.78
RSI Monthly	52.99
RSI Weekly	40.38
Sharpe ratio	0.06x
Sortino ratio	0.18
Total Return	-17.9%
Tr YTD	-18.06
Tr1m	-21.33%
Tr1w	-7.88%
Tr3m	-12.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Ratings	Strong Buy
Operating Income	$-173.3M
Operating margin	-211.1
Price target	$48.4
Price Target Change	$125

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	282,447,330%
Float Percent	76.2%
Net Borrowing	45,180,420
Shares Insiders	12.83%
Shares Institutions	18.98%
Shares Out	370,669,877
Shares Qo Q	8.51%
Shares Yo Y	17.9%
Short Float	0%
Short Ratio	0.19
Short Shares	0

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-179.7M
Average Volume	2,866.4x
Bv Per Share	0.51
CAPEX	$-3.9M
Ch1m	-21.33
Ch1w	-7.88
Ch1y	-11.04
Ch3m	-12.32
Ch6m	-32.24
Change	-0.92%
Change From Open	-1.83
Close	21.7
Days Gap	0.92
Depreciation Amortization	10,963,563.1
Dollar Volume	49,741.4
Earnings Date	2026-05-20
Earnings Time	bmo
EBIT	$-173.3M
EBITDA	$-162.6M
EPS	$-0.5
F Score	3
FCF	$-176.7M
FCF EV Yield	-9.13x
FCF Per Share	$-0.48
Financing CF	363,161,958
Fiscal Year End	December
Founded	2,009
Goodwill	3,631,043.4
Income Tax	$992,222
Investing CF	-142,978,955
Ipr	24.64
Iprfo	24.64
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-29
Ma150	28.35
Ma150ch	-24.15%
Ma20	24
Ma20ch	-10.41%
Net CF	43,275,192
Next Earnings Date	2026-05-22
Open	21.9
Optionable	No
Position In Range	31.03
Post Close	21.5
Postmarket Change Percent	-0.51
Postmarket Price	$21.39
Ppne	121,906,540.4
Price Date	2026-05-08
Ptbv Ratio	11.36
Relative Volume	0.81x
Revenue	82,082,809x
SBC By Revenue	3.64x
Share Based Comp	2,984,388
Tax By Revenue	1.21x
Tr6m	-32.24%
Volume	2,313.6
Z Score	1.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AAPG pay a dividend?

Capital-return profile for this ticker.

Performance

AAPG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AAPG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.0%

Float: +76.2% of shares outstanding

Insider ownership

+12.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AAPG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.8

Neutral momentum band

Price vs 200-day MA

-31.7%

50/200-day relationship not available

Beta (5Y)

0.72

Less volatile than the market

Sharpe ratio

0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AAPG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AAPG stock rating?

Ascentage Pharma Group International is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AAPG analysis?

The full report lives at /stocks/AAPG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AAPG?

The latest report frames AAPG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AAPG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.